Copper induces neuron-sparing, ferredoxin 1-independent astrocyte toxicity mediated by oxidative stress.
cell death
elesclomol
free radicals
glia
glioma
metal
Journal
Journal of neurochemistry
ISSN: 1471-4159
Titre abrégé: J Neurochem
Pays: England
ID NLM: 2985190R
Informations de publication
Date de publication:
10 2023
10 2023
Historique:
revised:
28
08
2023
received:
15
05
2023
accepted:
29
08
2023
pmc-release:
01
10
2024
medline:
26
10
2023
pubmed:
13
9
2023
entrez:
13
9
2023
Statut:
ppublish
Résumé
Copper is an essential enzyme cofactor in oxidative metabolism, anti-oxidant defenses, and neurotransmitter synthesis. However, intracellular copper, when improperly buffered, can also lead to cell death. Given the growing interest in the use of copper in the presence of the ionophore elesclomol (CuES) for the treatment of gliomas, we investigated the effect of this compound on the surround parenchyma-namely neurons and astrocytes in vitro. Here, we show that astrocytes were highly sensitive to CuES toxicity while neurons were surprisingly resistant, a vulnerability profile that is opposite of what has been described for zinc and other toxins. Bolstering these findings, a human astrocytic cell line was similarly sensitive to CuES. Modifications of cellular metabolic pathways implicated in cuproptosis, a form of copper-regulated cell death, such as inhibition of mitochondrial respiration or knock-down of ferredoxin 1 (FDX1), did not block CuES toxicity to astrocytes. CuES toxicity was also unaffected by inhibitors of apoptosis, necrosis or ferroptosis. However, we did detect the presence of lipid peroxidation products in CuES-treated astrocytes, indicating that oxidative stress is a mediator of CuES-induced glial toxicity. Indeed, treatment with anti-oxidants mitigated CuES-induced cell death in astrocytes indicating that oxidative stress is a mediator of CuES-induced glial toxicity. Lastly, prior induction of metallothioneins 1 and 2 in astrocytes with zinc plus pyrithione was strikingly protective against CuES toxicity. As neurons express high levels of metallothioneins basally, these results may partially account for their resistance to CuES toxicity. These results demonstrate a unique toxic response to copper in glial cells which contrasts with the cell selectivity profile of zinc, another biologically relevant metal.
Identifiants
pubmed: 37702109
doi: 10.1111/jnc.15961
pmc: PMC10591933
mid: NIHMS1930350
doi:
Substances chimiques
Copper
789U1901C5
Ferredoxins
0
Antioxidants
0
Zinc
J41CSQ7QDS
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
277-295Subventions
Organisme : NINDS NIH HHS
ID : R01 NS043277
Pays : United States
Organisme : NINDS NIH HHS
ID : R56 NS043277
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY024481
Pays : United States
Organisme : NIA NIH HHS
ID : T32 AG021885
Pays : United States
Informations de copyright
© 2023 International Society for Neurochemistry.
Références
Nature. 2010 Jun 3;465(7298):645-8
pubmed: 20463663
Biomolecules. 2021 Oct 28;11(11):
pubmed: 34827595
J Neurochem. 2007 Aug;102(4):1369-82
pubmed: 17484727
Neurotoxicology. 2023 Mar;95:205-217
pubmed: 36796651
Brain Res. 1979 Oct 26;176(1):91-100
pubmed: 487185
Prog Neurobiol. 2014 May;116:33-57
pubmed: 24440710
Exp Neurol. 1998 Nov;154(1):241-58
pubmed: 9875285
Oncogene. 2014 Sep 25;33(39):4778-85
pubmed: 24166506
Proc Natl Acad Sci U S A. 2019 Jun 18;116(25):12167-12172
pubmed: 31160463
Clin Cancer Res. 2019 Jan 15;25(2):844-855
pubmed: 30322879
J Neurochem. 1997 May;68(5):1836-45
pubmed: 9109508
Neuroscience. 1988 Jan;24(1):67-79
pubmed: 3368058
Neurochem Res. 2015 Jan;40(1):15-26
pubmed: 25344926
EMBO J. 1993 Apr;12(4):1355-62
pubmed: 8467794
Sci Rep. 2015 Nov 27;5:17367
pubmed: 26610392
Nat Chem Biol. 2019 Jul;15(7):681-689
pubmed: 31133756
Biochem Pharmacol. 2015 Feb 1;93(3):266-76
pubmed: 25550273
Front Oncol. 2022 Aug 18;12:967159
pubmed: 36059638
Neurobiol Dis. 2000 Aug;7(4):310-20
pubmed: 10964603
FEBS J. 2014 Mar;281(6):1659-78
pubmed: 24479872
Trends Endocrinol Metab. 2023 Jan;34(1):21-33
pubmed: 36435678
Mol Oncol. 2021 Dec;15(12):3527-3544
pubmed: 34390123
Gynecol Oncol. 2018 Dec;151(3):422-427
pubmed: 30309721
Sci Transl Med. 2016 Aug 31;8(354):354re3
pubmed: 27582061
Nat Commun. 2017 May 02;8:15132
pubmed: 28462931
Bioorg Med Chem. 2009 Mar 1;17(5):1803-10
pubmed: 19230679
Cells. 2023 Feb 21;12(5):
pubmed: 36899819
Glia. 1991;4(1):91-100
pubmed: 1675625
J Med Chem. 2002 Sep 26;45(20):4549-58
pubmed: 12238934
Free Radic Biol Med. 2012 May 15;52(10):2142-50
pubmed: 22542443
Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19345-50
pubmed: 18032601
Lancet. 2007 Feb 3;369(9559):397-408
pubmed: 17276780
J Neurochem. 2004 Feb;88(3):657-67
pubmed: 14720215
Signal Transduct Target Ther. 2022 May 13;7(1):158
pubmed: 35562341
Nat Neurosci. 2016 Mar;19(3):432-42
pubmed: 26854804
J Nutr. 2000 Apr;130(4):719-27
pubmed: 10736320
J Trace Elem Med Biol. 2015 Oct;32:168-76
pubmed: 26302925
Proc Natl Acad Sci U S A. 2001 May 8;98(10):5556-9
pubmed: 11331777
Biochem J. 2002 Aug 15;366(Pt 1):97-107
pubmed: 11994046
J Neurosci. 2001 Nov 1;21(21):8348-53
pubmed: 11606622
Front Immunol. 2023 Feb 06;14:1082974
pubmed: 36814929
BMC Cancer. 2023 Mar 13;23(1):237
pubmed: 36915038
PLoS One. 2020 Jan 16;15(1):e0227887
pubmed: 31945125
J Biol Chem. 2007 Jun 1;282(22):16068-78
pubmed: 17389590
Front Mol Biosci. 2021 Aug 24;8:711227
pubmed: 34504870
BMC Bioinformatics. 2006 Mar 09;7:123
pubmed: 16526949
Aging Cell. 2019 Jun;18(3):e12937
pubmed: 30815970
Exp Neurol. 2003 Nov;184(1):326-36
pubmed: 14637103
Neurotox Res. 2014 Jul;26(1):78-84
pubmed: 24385258
Front Genet. 2022 Dec 12;13:992995
pubmed: 36579333
Neurosci Lett. 2023 Jul 13;809:137305
pubmed: 37210067
Hippokratia. 2018 Jul-Sep;22(3):105-112
pubmed: 31641331
Chem Sci. 2022 Apr 4;13(18):5289-5304
pubmed: 35655557
Int J Mol Sci. 2020 Dec 04;21(23):
pubmed: 33291628
FASEB J. 2020 Mar;34(3):3646-3657
pubmed: 31960518
Nat Cancer. 2020 Feb;1(2):235-248
pubmed: 32613204
PLoS One. 2012;7(1):e29798
pubmed: 22253786
Int J Mol Sci. 2013 Mar 15;14(3):6044-66
pubmed: 23502468
Neurochem Res. 2019 Oct;44(10):2288-2300
pubmed: 30788754
Biomed Pharmacother. 2021 Jan;133:111058
pubmed: 33378970
J Inorg Biochem. 2013 Sep;126:1-6
pubmed: 23707906
Neurochem Res. 2015 Dec;40(12):2570-82
pubmed: 25428182
Neuro Oncol. 2019 Nov 1;21(Suppl 5):v1-v100
pubmed: 31675094
Biochem J. 1993 Apr 1;291 ( Pt 1):193-8
pubmed: 8385930
J Neurochem. 2009 Jul;110(1):106-17
pubmed: 19453299
Hum Mol Genet. 2000 Mar 22;9(5):795-801
pubmed: 10749987
J Inorg Biochem. 2009 Oct;103(10):1375-9
pubmed: 19709751
Int J Mol Sci. 2023 Jun 26;24(13):
pubmed: 37445846
Neurosci Lett. 1989 Aug 28;103(2):162-8
pubmed: 2570387
Autophagy. 2023 Jul;19(7):1982-1996
pubmed: 36622894
Biochem Pharmacol. 2000 Jan 1;59(1):95-104
pubmed: 10605938
Neurochem Res. 2011 May;36(5):894-903
pubmed: 21318477
Brain Res Bull. 2023 May;196:59-67
pubmed: 36935053
Glia. 2002 Dec;40(3):337-49
pubmed: 12420313
J Neurosci. 2000 Dec 1;20(23):8831-7
pubmed: 11102491
BMC Med Genomics. 2015 Oct 22;8:68
pubmed: 26493598
J Cereb Blood Flow Metab. 2007 Feb;27(2):219-49
pubmed: 16835632
Int J Mol Sci. 2022 Apr 30;23(9):
pubmed: 35563385
Curr Biol. 2011 Nov 8;21(21):R877-83
pubmed: 22075424
Antioxid Redox Signal. 2011 Oct 15;15(8):2249-63
pubmed: 20849376
Biometals. 2015 Feb;28(1):1-9
pubmed: 25307560
Nat Metab. 2022 Jun;4(6):651-662
pubmed: 35760871
Toxicol Appl Pharmacol. 1997 Feb;142(2):229-42
pubmed: 9070344
Signal Transduct Target Ther. 2022 Nov 23;7(1):378
pubmed: 36414625
Genomics. 2023 Mar;115(2):110601
pubmed: 36889365
Glia. 2010 Aug;58(10):1168-76
pubmed: 20544852
Brain Res Bull. 2001 May 15;55(2):133-45
pubmed: 11470309
Am J Transl Res. 2022 Nov 15;14(11):8085-8102
pubmed: 36505293
Trends Neurosci. 1989 Mar;12(3):94-101
pubmed: 2469224
Eur J Neurosci. 2002 Sep;16(6):1015-24
pubmed: 12383230
Exp Cell Res. 2010 Oct 15;316(17):2961-8
pubmed: 20620137
Biochim Biophys Acta. 1985 Jan 21;827(1):36-44
pubmed: 2981555
J Neurochem. 1995 Oct;65(4):1562-8
pubmed: 7561850
Neurochem Int. 2015 Nov;90:36-45
pubmed: 26187063
Science. 2022 Mar 18;375(6586):1254-1261
pubmed: 35298263
Eur J Neurosci. 1998 Aug;10(8):2523-31
pubmed: 9767383
Metallomics. 2018 Dec 12;10(12):1777-1791
pubmed: 30420986
Mol Pharmacol. 1998 Mar;53(3):355-69
pubmed: 9495799
Glia. 2019 Apr;67(4):759-774
pubmed: 30623988
Neuro Oncol. 2012 Jun;14(6):701-11
pubmed: 22570425
Brain Res. 1998 Dec 7;813(2):254-61
pubmed: 9838151
J Biol Chem. 2002 Aug 30;277(35):32353-9
pubmed: 12058024
J Clin Oncol. 2013 Mar 20;31(9):1211-8
pubmed: 23401447
Elife. 2016 Jun 10;5:
pubmed: 27282387
Handb Clin Neurol. 2013;113:1745-54
pubmed: 23622398
Neurochem Res. 2023 Jul;48(7):2241-2252
pubmed: 36914795
J Immunol Res. 2022 Mar 23;2022:2233906
pubmed: 35411309
J Neurochem. 2000 Nov;75(5):1878-88
pubmed: 11032877
J Neurochem. 2007 May;101(3):794-805
pubmed: 17250685
Nat Commun. 2015 May 13;6:7066
pubmed: 25967870
J Neurochem. 1997 Dec;69(6):2612-5
pubmed: 9375696
J Neurosci. 1997 Feb 1;17(3):932-40
pubmed: 8994048
Arch Toxicol. 2016 Jan;90(1):1-37
pubmed: 26343967
Nat Chem Biol. 2023 Feb;19(2):206-217
pubmed: 36280795
Metallomics. 2014 Dec;6(12):2223-9
pubmed: 25322772
Front Mol Biosci. 2021 Sep 17;8:741316
pubmed: 34604310
Exp Neurol. 1999 Jan;155(1):118-27
pubmed: 9918711
Mol Cancer Ther. 2008 Aug;7(8):2319-27
pubmed: 18723479
N Engl J Med. 2005 Mar 10;352(10):987-96
pubmed: 15758009
Sci Rep. 2019 Apr 1;9(1):5406
pubmed: 30932010
Cancer Discov. 2021 Mar;11(3):575-590
pubmed: 33558264
Curr Protoc Neurosci. 2008 Jul;Chapter 7:Unit 7.18
pubmed: 18633999
EMBO J. 1994 Jun 15;13(12):2870-5
pubmed: 8026472